Capella 4020 Assessment 3 Improvement Plan in Service Presentation
Capella 4020 Assessment 3 Improvement Plan in Service Presentation Name Capella university NURS-FPX 4020 Improving Quality of Care and Patient Safety Prof. Name Date Improvement Plan In-Service Presentation Greetings! My name is Priscilla, and I’m here to give you the safe medication administration improvement plan, which will address Medication Administration Errors (MAEs) that result in Adverse Drug Events (ADEs), as mentioned in assessment two. Outline This presentation will cover the following topics: Health care problem Purpose and goals of the in-service session Need and process to improve safety outcomes Role and importance of audience Resources and activities for engagement Medication Administration Errors MAEs are defined as errors that occur during drug administration. The administration procedure is the final step in pharmaceutical management before final documentation. Most of these errors are made by nurses, the most significant medical personnel delivering medications to patients (Asefa et al., 2021). These errors can arise because of the administration of the incorrect medicine, dosage, or procedure at the incorrect time or to the incorrect patient (Ayorinde & Alabi, 2019). Medication administration must be done safely to safeguard patient safety and avoid ADEs. ADEs can cause mild to severe side effects, leading to in serious complications or mortality. In medical facilities, ADEs are responsible for adverse patient safety effects (Bangwal et al., 2020). The safe drug administration improvement plan is a holistic effort aimed at addressing the issues raised by MAEs. Purpose and Goals of In-Service Session Purpose This in-service session on safe drug administration, focusing on reducing MAEs that cause ADEs, improves nurses’ understanding, abilities, and compliance with standard procedures (Wondmieneh et al., 2020). The session’s objective is to equip nurses with updated knowledge on ADEs to prevent the adverse effects of medication interactions caused by MAEs. The implementation of Electronic Health Record (EHR) and Barcoding Medication Administration (BCMA) systems assists in the reduction of MAEs and enables nurses to manage ADEs better (Grailey et al., 2023). Nurses can render informed judgments during medication administration if they better understand the adverse effects of MAEs, particularly ADEs. The training session encourages nurses to practice analytical abilities or strategies when administering drugs. Nurses can help to prevent adverse occurrences by recognizing and minimizing risks through their expertise (Marufu et al., 2022). Goals The following objectives are pertinent and attainable during the in-service session: Provide nurses with easily accessible tools, such as pharmaceutical reference guides, medication interaction databases, and organizational regulations and guidelines, to support informed decision-making and MAE management (Shahmoradi et al., 2021). Nurses will be aware of high-alert or complex drugs, their particular managing demands, administering practices, and measures to reduce the possibility of MAEs (Zyoud et al., 2019). By the end of the session, nurses will understand error prevention strategies and tools, including BCMA, verification, and digital prescriptions through EHR systems, to improve proficiency and validation procedures during administering drugs (Lunt & Mathieson, 2020). The session will encourage nurses to report and gain insight into drug errors. The seminar will emphasize the significance of report systems for incidents, for example, the use of a Medication Error Reporting System (MERS). It also emphasize on the implementation of preventative measures to avoid such mistakes in the future. (Afaya et al., 2021). Need and Process to Improve Safety Outcomes Need To prevent ADEs, there is a need to enhance safety outcomes related to MAEs (Kuklik et al., 2019). According to research, approximately 7000 deaths occur in the United States because of MAEs, with almost 400,000 occurrences of avoidable patient harm. MAEs caused ADEs in 25% of those admitted to hospitals. According to Fathy et al. (2020), the global financial effect of MAE costs approximately 42 billion dollars annually. This evidence highlights the critical need for comprehensive strategies to reform the medical sector to provide safety and more effective care. It is critical to deal with MAEs holistically and establish procedures that successfully reduce the incidence of avoidable MAEs, which result in ADEs and compromise patient safety (Kuklik et al., 2019). Process The safety improvement process intends to develop suitable medication administration practices to minimize ADEs in medical centers. This approach comprises evidence-based efforts to encourage patient safety. The first stage in the process is providing educational opportunities and training to medical staff to acquire the appropriate knowledge and competencies. Drug security expertise and comprehension also encourage involvement in continuing learning activities (Farzi et al., 2020). The second step is the execution of the Medication Reconciliation (MR) strategy. The MR involves assessing new drug prescription to those already in use, checking correctness, and eliminating disparities. MR has been shown to help lower MAEs and prevent potential ADEs during hospitalization. Nurses can help minimize adverse effects of medication and promote patient safety by doing MR carefully (Ceschi et al., 2020) In the third step of the process to improve safety, technological tools are employed to eliminate MERs and increase performance. Incorporating BCMA and EHR systems assists in lowering the probability of serious medical complications. Nurses can reliably validate medication codes and dispense medications to patients appropriately by using BCMA (Barakat & Franklin, 2020). Furthermore, drug administration processes are built using the Computerized Physician Order Entry (CPOE) system. Nurses can use CPOE to describe pharmacological interactions to improve medication accuracy and avoid adverse events (Mogharbel et al., 2021). The final step of the improvement process involves enhancing the culture for MAE reporting, learning, and continuous improvement and enabling nurses and other healthcare providers to report MAE incidents if they happen (Obaid et al., 2023). These strategies focused on improving interactions, such as structured communication tools and interdisciplinary training, to lessen drug delivery mistakes and improve patient safety. Nurses can reduce drug-related hazards and promote safer drug administration methods by taking part in open communication and cooperating with other medical personnel (Dirik et al., 2019). Role and Importance of Audience To develop a successful improvement plan based on safe drug delivery, properly communicating the audience’s role is critical. The audience’s awareness of their duties can be improved by open communication, helps in the effectiveness of the plan (Dirik et al., 2019). Policymakers and the board of director’s members must be involved in developing supportive guidelines, distributing adequate funds, and offering strategic leadership. Their dedication and participation in the improvement plan are critical to its accomplishment, as they